Use of the interleukin 6 inhibitor tocilizumab in Japanese...

  • Main
  • 2020 / 10
  • Use of the interleukin 6 inhibitor tocilizumab in Japanese...
Respiratory Investigation 2020 / 10

Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series

Nakamura, Hideta, Miyagi, Kazuya, Otsuki, Mariko, Higure, Yuuri, Nishiyama, Naoya, Kinjo, Takeshi, Nakamatsu, Masashi, Haranaga, Shusaku, Tateyama, Masao, Fujita, Jiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Respiratory Investigation
DOI:
10.1016/j.resinv.2020.09.006
Date:
October, 2020
File:
PDF, 607 KB
2020
Conversion to is in progress
Conversion to is failed